PI3Kδ was reported to promote breast and prostate cancer cell proliferation via dampening of PTEN activity and to induce colorectal cancer cell growth and invasion by activating the AKT/GSK3β/β-catenin signaling pathway68,69. This evidence concerns the gene GSK3B and prostate cancer.